Latest Breaking News On - Mirum pharmaceuticals - Page 1 : comparemela.com

Frazier Life Sciences Management L P Grows Stock Holdings in Mirum Pharmaceuticals, Inc (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

United statesStifel nicolausEric bjerkholtSaira ramasastryNews ratings for mirum pharmaceuticals dailyWetzel investment advisors incQuest partnersChina universal asset management coStepstone groupInsider transactions at mirum pharmaceuticalsQuarter for mirum pharmaceuticalsMorgan stanleyMirum pharmaceuticals stock downMirum pharmaceuticalsCantor fitzgeraldExchange commission

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Compensation committee of mirum board directorsMirum pharmaceuticals incMirum pharmaceuticalsCompensation committeeNasdaq listing rule

Mirum Pharmaceuticals, Inc (NASDAQ:MIRM) Director Sells $128,400 00 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) Director Saira Ramasastry sold 5,000 shares of Mirum Pharmaceuticals stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $25.68, for a total value of $128,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]

New yorkUnited statesSaira ramasastrySecurities exchange commissionQuarter for mirum pharmaceuticalsInstitutional investors weigh in on mirum pharmaceuticalsMirum pharmaceuticalsNews ratings for mirum pharmaceuticals dailyMirum pharmaceuticals tradingSwiss national bankYork state common retirement fundWetzel investment advisors incJanney montgomery scottMorgan stanleyMirum pharmaceuticals incGet free report

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesIntrahepatic cholestasisChris peetzEuropean commissionCommittee for orphan medicinal productsDrug administrationMirum pharmaceuticals incHealth canadaMirum pharmaceuticalsEuropean committeeMedicinal productsHuman useProgressive familial intrahepatic cholestasisOrphan medicinal productsOrphan drug designationBreakthrough therapy

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake immunotherapeuticsArcutis biotherapeuticsZealand pharmaVerona pharmaBridgebio pharmaMohit bansalNeurocrine biosciencesIovance biotherapeuticsWells fargoAlnylam pharmaceuticalsRhythm pharmaceuticalsApellis pharmaceuticalsArrowhead pharmaceuticalsAmicus therapeuticsXenon pharmaceuticalsMadrigal pharmaceuticals